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Stroke remains a major cause of death and disability with ~16.9 million new patients 
sustaining a clinical event worldwide1. 40% of ischaemic strokes are due to internal carotid 
artery thromboembolism with two-thirds of patients having ≤50% carotid luminal stenosis 
(North American Symptomatic Carotid Endarterectomy Trial (NASCET)2 defined)3. 
However, the degree of stenosis remains the major determinant of patient risk assessment in 
current practice. This occurred as luminal stenosis can be easily quantified using ultrasound, 
which was the only validated imaging modality available during the design of landmark 
clinical trials in 1980s and 1990s.  
 
Histopathological studies have improved our understanding of lesion instability, highlighting 
that luminal stenosis is not the only marker of future risk and that the presence of specific 
plaque features may be equally important4. In particularly, carotid intra-plaque haemorrhage 
(IPH) has been showed to be a risk factor for ischaemic cerebrovascular events. Immature 
neovessels are thought to be the principal source of IPH, allowing plasma and red blood cells 
to leak into the developing plaque. The red cells subsequently undergo apoptosis (Figure 1), 
which initiates complex cascade processes, including cellular degradation and cytophagy that 
act to promote lipid accumulation. IPH is therefore an important driving force for plaque 
progression5. In an 18-month follow-up study of asymptomatic patients with 50-70% luminal 
stenosis, percentage change in wall volume and lipid-rich necrotic core volume was 
significantly higher in the group of patients with IPH6.  
 
High-resolution magnetic resonance imaging (hrMRI) can reliably identify IPH, which 
appears high intensity in T1-weighted images. MRI-identified IPH has been showed to be 
associated with patient clinical presentations and subsequent ischaemic cerebrovascular 
events in several small cohort studies. A meta-analysis demonstrated that the presence of IPH 
was associated with a ~6-fold higher risk for events (Hazard ratio = 5.69) in 8 studies with 
689 patients and the annualized event rate in subjects with detectable IPH was 17.7% 
compared with 2.4% in patients without IPH7.  However, the prevalence of IPH in differing 
patient cohort remains uncertain. Data on the prevalence of IPH in symptomatic patients (n = 
1,000) is due to be released shortly from a recently completed multi-center clinical trial 
(CARE-II study)8. In the population-based Rotterdam study (n = 5,240; age >45 years; mean 
age = 70.3 years), the prevalence of IPH was high (34.5% of participants; n = 1,006) in 
plaques causing carotid wall thickness ≥2.5 mm9.  
 
Kurosaki et al10 reported that IPH appeared in 96 carotid atherosclerotic plaques in 96 
subjects in 1,190 individuals (8.1%) who underwent annual medical check-up. During a mean 
follow-up period of 53 months, 16 (5 hemorrhagic and 11 ischemic events) patients 
experienced cerebrovascular events. Among these 16 patients, 4 of them with and 3 without 
IPH presenting in the carotid plaque. Among those ischemic events caused by a carotid lesion 
(n = 3), 2 events were associated with IPH. These observations indicated that in a general 
population, only 2.1% lesions with IPH would be responsible for ischemic events in ~4.5 
years. Kurosaki et al10 also noted that diabetic patients with IPH were at a higher risk of 
experiencing ischemic events. Among 8 diabetic patients with IPH presenting in the carotid 
plaque, 3 experienced ischemic events. This study again reinforces the association between 
IPH and cerebrovascular events. However, it highlights the challenge in identifying higher 
risk carotid lesions within the general population, as the annual event rate for hrMRI-defined 
IPH was extremely low at 0.47%. Thus, the probability of future cerebrovascular events 
cannot be solely based on the presence of IPH and other biomarkers that improve risk 
stratification are urgently required. 
 
Although wall thickness (alternatively, degree of luminal stenosis) also cannot serve as a 
robust biomarker for refined risk stratification, high-risk atherosclerotic plaque features are 
associated with maximum carotid wall thickness. IPH and lipid appeared in 5.6% of and 11.2% 
of plaques with thickness of 2.0-2.5 mm, and in 44.5% of and 37.4% of plaques with 3.7-9.9 
mm thickness9. Both of these two higher risk features appeared simultaneously in 9.3% of 
plaques (17.7% of subjects)9. As the majority of ischemic events are induced by plaque 
rupture, high mechanical loading within the plaque structure due to blood pressure may be 
useful to assess the likelihood of rupture11, as fibrous cap integrity may be compromised if 
such loading exceeds its material strength. A pilot study in the coronary arteries demonstrated 
that mechanical analysis may improve risk prediction 2-3 fold for individual high-risk 
features12.  
 
Integration of luminal stenosis, plaque composition and mechanical loading has potential to 
improve the prediction of future ischemic events. Rigorously designed large-scale studies are 
now warranted to provide evidence that these methods improves patient care. 
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Figure 1. Red blood cells may leak from neovessels undergone apoptosis and contributed to 
the lipid accumulation and plaque progression (A: H&E stain showing the overall structure of 
a carotid plaque with severe luminal stenosis; B: local view of the area enclosed by the dash-
box in A showing a neovessel; C: leaked red blood cells in the process of apoptosis; Red 
asterisks: neovessels; Green arrows: apoptotic red blood cells)   
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